Syn-Tech Chen.&pharm (1777) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 生泰

Syn-Tech Chen.&pharm (1777) reported revenue of NT$101 million for Oct 2026, -24.5% year on year and -24.0% from the previous month. Revenue for Jan–Oct 2026 was NT$1.08 billion (-2.6% year on year).

In Oct 2026, it ranked No. 72 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$111.3 million24/10Nov 2024 NT$108.5 millionDec 2024 NT$94.5 millionJan 2025 NT$96.5 millionFeb 2025 NT$135.2 million25/02Mar 2025 NT$84 millionApr 2025 NT$109.5 millionMay 2025 NT$117.1 millionJun 2025 NT$98.2 million25/06Jul 2025 NT$113.4 millionAug 2025 NT$114.6 millionSep 2025 NT$108.8 millionOct 2025 NT$133.8 million25/10Nov 2025 NT$106.4 millionDec 2025 NT$82.8 millionJan 2026 NT$86.7 millionFeb 2026 NT$101.6 million26/02Mar 2026 NT$87.3 millionApr 2026 NT$101.3 millionMay 2026 NT$109.2 millionJun 2026 NT$125.9 million26/06Jul 2026 NT$102.1 millionAug 2026 NT$134.8 millionSep 2026 NT$132.8 millionOct 2026 NT$101 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$101 million-24.5%-24.0%
Sep 2026NT$132.8 million+22.1%-1.5%
Aug 2026NT$134.8 million+17.7%+32.1%
Jul 2026NT$102.1 million-10.0%-18.9%
Jun 2026NT$125.9 million+28.2%+15.2%
May 2026NT$109.2 million-6.7%+7.9%
Apr 2026NT$101.3 million-7.5%+16.0%
Mar 2026NT$87.3 million+3.9%-14.0%
Feb 2026NT$101.6 million-24.9%+17.1%
Jan 2026NT$86.7 million-10.1%+4.7%
Dec 2025NT$82.8 million-12.4%-22.2%
Nov 2025NT$106.4 million-2.0%-20.5%
Oct 2025NT$133.8 million+20.2%+23.0%
Sep 2025NT$108.8 million+2.2%-5.1%
Aug 2025NT$114.6 million-6.6%+1.1%
Jul 2025NT$113.4 million+11.7%+15.5%
Jun 2025NT$98.2 million-24.3%-16.2%
May 2025NT$117.1 million+1.8%+6.9%
Apr 2025NT$109.5 million+11.4%+30.3%
Mar 2025NT$84 million-3.3%-37.9%
Feb 2025NT$135.2 million+33.6%+40.2%
Jan 2025NT$96.5 million+18.1%+2.1%
Dec 2024NT$94.5 million+6.7%-13.0%
Nov 2024NT$108.5 million+0.5%-2.5%
Oct 2024NT$111.3 million+47.7%+4.6%

Jan–Oct 2026 cumulative: NT$1.08 billion (-2.6% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Syn-Tech Chen.&pharm vs PEC / Syn-Tech Chen.&pharm vs Lotus Pharm / Syn-Tech Chen.&pharm vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16